Product Information
Name:BKIDC-1553
Brand:Targetmol
Description:BKIDC-1553, an orally active antiglycolytic agent and bumped kinase inhibitor-derived compound, has a predicted half-life of approximately 17 hours in humans. It inhibits CYP2C8 and Angiotensin Converting Enzyme, making it suitable for cancer research [1].
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:389.45
Formula:C22H23N5O2
Color/Form:Solid
Technical inquiry about: BKIDC-1553
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.